Hepatic fibrosis as an additional risk factor for the development of cardiovascular disorders in patients with type 2 diabetes mellitus with non-alcoholic fatty liver disease

Hepatic fibrosis as an additional risk factor for the development of cardiovascular disorders in patients with type 2 diabetes mellitus with non-alcoholic fatty liver disease

The aim of the study was to determine the relationship between the degree of progression of liver fibrosis and the risk of cardiovascular complications in patients with Type 2 diabetes mellitus (DM) with non-alcoholic fatty liver disease (NAFLD). The study included 110 patients with Type 2 diabetes...

Full description

Saved in:

Bibliographic Details
Main Authors:	O.M. Bilovol, I.I. Kniazkova, O.V. Zemlianitsyna, I.P. Dunaieva, I.P. Romanova, O.D. Kurilo, V.M. Sinaiko, N.O. Kravchun
Format:	Article
Language:	English
Published:	Dnipro State Medical University 2021-06-01
Series:	Medičnì Perspektivi
Subjects:	type 2 diabetes mellitus non-alcoholic fatty liver disease cardiovascular diseases
Online Access:	http://journals.uran.ua/index.php/2307-0404/article/view/234639
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Improvement of non-alcoholic fatty liver disease treatment
by: P. I. Seliverstov, et al.
Published: (2014-10-01)

Arterial stiffness in non-alcoholic fatty liver disease
by: T.V. Chendey, et al.
Published: (2024-06-01)

Non-Alcoholic Fatty Liver Disease in Cardiac Patients with Overweight and Obesity
by: I. V. Logacheva, et al.
Published: (2019-01-01)

Functional-morphological changes in non-alcoholic fatty liver disease after bariatric operations
by: Iu. I. Sedletskii, et al.
Published: (2019-02-01)

Improvement of liver fibrosis verification using new minimally invasive markers in patients with chronic diffuse liver diseases
by: Yu.M. Stepanov, et al.
Published: (2022-12-01)

Clinical and anamnestic characteristics of patients with clinical manifestations of peripheral artery disease as a function of Т(–786)С polymorphism of the endothelial NO-synthase gene promoter
by: V.I. Tseluyko, et al.
Published: (2016-09-01)

Epidemiologic features of non-alcoholic fatty liver disease in Russia
by: O. M. Drapkina, et al.
Published: (2014-10-01)

ANALYSIS OF SCHOOLCHILDREN’S HEALTH IN THE MODERN ENVIRONMENT AS EXEMPLIFIED BY POLTAVA REGION
by: O.D. Sargosh, et al.
Published: (2017-03-01)

Practical Aspects of Clinical Manifestations, Pathogenesis and Therapy of Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease: Expert Opinion
by: V. V. Tsukanov, et al.
Published: (2023-11-01)

Prevalence of non-alcoholic fatty liver disease in out-patients of the Russian Federation: DIREG 2 study results
by: V. T. Ivashkin, et al.
Published: (2015-12-01)

SUBCUTANEOUS ADIPOSE TISSUE IN FEMALE PATIENTS WITH IRON DEFICIENCY ANEMIA AND OBESE WOMEN DOES NOT DIFFER IN THE EXPRESSION OF IKBΑ*
by: V.M. Nedoborenko, et al.
Published: (2018-10-01)

Efficacy and Safety of Bicyclol Treatment for Non-Alcoholic Fatty Liver Disease: Results of a Cohort Study
by: I. Yu. Pirogova, et al.
Published: (2018-09-01)

An Effect of Ursodeoxycholic Acid on Inflammation, Steatosis and Liver Fibrosis and Atherogenesis Factors in Patients with Non-Alcoholic Fatty Liver Disease: Results of the USPEH Study
by: M. V. Mayevskaya, et al.
Published: (2020-01-01)

Pathogenic role of lipids in non-alcoholic fatty liver disease
by: Yu. O. Shulpekova
Published: (2012-02-01)

Interrelation of blood lipid spectrum, level of systemic inflammation and mass of body in patients with coronary heart disease in combination with nonalcoholic fatty liver disease and their dynamics in terms of secondary prevention
by: Kuryata O.V., et al.
Published: (2014-11-01)

Clinical features of hypertension in patients with normal weight and overweight
by: V.I. Bulda, et al.
Published: (2024-03-01)

Serum biomarkers in the metabolic dysfunction-associated steatotic liver fibrosis diagnosis in children
by: Yu.M. Stepanov, et al.
Published: (2024-12-01)

COVID-19 and arterial hypertension: whether normal blood pressure is a sign of a benign course of COVID-19
by: O.V. Kuryata, et al.
Published: (2023-12-01)

Features of pancreatic parenchyma fibrosis in the comorbid course of chronic pancreatitis and chronic obstructive pulmonary disease
by: I.V. Dudka, et al.
Published: (2024-12-01)

Clinical case of community-aquaired pneumonia on the background of previously undiagnosed occupational pulmonary fibrosis. Is occupational history important?
by: O. G. Cherkasova, et al.
Published: (2018-10-01)

Effect of weight loss on the course of non-alcoholic fatty liver disease: results of 6-month follow-up
by: L. V. Chesnokova, et al.
Published: (2015-03-01)

Results of protease inhibitor instructions in patients in acute burning disease
by: O.M. Lynnyk, et al.
Published: (2022-03-01)

Phenotypes of Non-Alcoholic Fatty Liver Disease in Different Regions of the Russian Federation, Diagnostic and Therapeutic Approach in Clinical Practice
by: V. T. Ivashkin, et al.
Published: (2023-08-01)

Metabolic and Genetic Determinants of Lipid Metabolism Disruption in Non-Alcoholic Fatty Liver Disease
by: O. Yu. Kytikova, et al.
Published: (2020-05-01)

Comorbidity in in patients with relapsing-remitting multiple sclerosis
by: O.V. Somilo, et al.
Published: (2024-10-01)

Peculiarities of vitamin D metabolism in diabetic kidney disease
by: V.M. Yerokhovych, et al.
Published: (2024-12-01)

Methodical approaches in experimental modelling of non-alcoholic fatty liver disease
by: N. V. Bivalkevich, et al.
Published: (2015-09-01)

The consequence of biomarkers of myocardial fibrosis in the prediction of arrhythmias in patients with hypertension in combination with coronary heart disease (literature review)
by: V.P. Ivanov, et al.
Published: (2020-12-01)

Pleiotropic effects of statins in treatment of generalized periodontitis in patients with coronary artery disease: clinical and experimental study (literature review)
by: O.I. Martovlos (Hodovana), et al.
Published: (2022-06-01)

The Role of the Microbiome and Intestinal Mucosal Barrier in the Development and Progression of Non-Alcoholic Fatty Liver Disease
by: T. S. Krolevets, et al.
Published: (2020-12-01)

Clinical and Pathogenetic Parallels of Nonalcoholic Fatty Liver Disease and Gallstone Disease
by: Aleksey O. Bueverov
Published: (2019-03-01)

Autoinflammatory diseases. Part 1: concept, classification, immunobiology, diagnosis
by: O.V. Shvaratska, et al.
Published: (2024-11-01)

Association of leptin receptor Gln223Arg genetic polymorphism with obesity and non-alcoholic fatty liver disease
by: A. V. Morozova, et al.
Published: (2014-09-01)

Impact of war on the development and progression of chronic kidney disease among residents of frontline regions (Kharkiv): first results of Save Kidneys Study as part of the ISN Clinical Research Program
by: O.I. Chub, et al.
Published: (2024-09-01)

Liver and Nutrition. An Optimal Diet for Non-Alcoholic Fatty Liver Disease
by: M. V. Mayevskaya, et al.
Published: (2018-11-01)

Clinical course of herpes virus skin diseases on the background of HIV
by: T.I. Liadova, et al.
Published: (2022-06-01)

Non-Alcoholic Fatty Liver Disease, Bile Acids and Intestinal Microbiota
by: R. V. Maslennikov, et al.
Published: (2018-09-01)

Fatty Acids of Erythrocyte Membranes and Blood Serum as Possible Predictors of Exacerbation in Patients with Inflammatory Bowel Diseases
by: M. V. Kruchinina, et al.
Published: (2025-02-01)

The enigmatic diploid Chenopodium ucrainicum (Chenopodiaceae / Amaranthaceae s. l.): geographical, ecological, and phytosociological patterns as clues to its origin
by: Shynder O.I., et al.
Published: (2024-12-01)

Electrical and Viscoelastic Parameters of Erythrocytes as a Part of Diagnostic Models for Differentiating Fatty Liver Disease of Mixed Genesis from Non-Alcoholic and Alcohol-Related Fatty Liver Disease
by: M. V. Kruchinina, et al.
Published: (2024-08-01)